| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Phreesia, Inc.'s insiders have reduced their positions by a net 536 shares worth roughly $6K. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. PHR sits in the Health Care Technology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.39M | $17.38M | - | |
| Pres | 842.5K | $10.54M | - | |
| Pres | 224.1K | $2.80M | - | |
| VP | 168.9K | $2.11M | - | |
| Other | 163.5K | $2.05M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2021 | Linetsky David71 | SVP, Life Sciences | Sell | 5,136 | $64.28 | $330,119.48 | -3.3% | |
| Jan 5, 2021 | Roberts Evan72 | Chief Operating Officer | Sale+OE | 101,713 | $52.68 | $5,358,582.60 | -2.7% | |
| Jan 4, 2021 | Smith Mark Douglas69 | Director | Sale+OE | 6,000 | $52.57 | $315,410.85 | -21.6% | |
| Jan 4, 2021 | Vanduyn Amy Beth66 | SVP, Human Resources | Sale+OE | 500 | $54.26 | $27,128.00 | -1.1% | |
| Dec 24, 2020 | Cahill Edward L59 | Director | Sell | 24,370 | $57.22 | $1,394,480.64 | -25.6% | |
| Dec 17, 2020 | Pegus Cheryl | Director | Sale+OE | 31,147 | $55.91 | $1,741,581.07 | -42.6% | |
| Oct 23, 2020 | Altier Thomas | Chief Financial Officer | Sale+OE | 94,906 | $37.70 | $3,577,754.04 | -22.8% | |
| Oct 21, 2020 | Vanduyn Amy Beth66 | SVP, Human Resources | Sale+OE | 10,834 | $35.00 | $379,190.00 | -17.6% | |
| Oct 12, 2020 | Altier Thomas | Chief Financial Officer | Sale+OE | 6,779 | $32.13 | $217,778.76 | -4.1% | |
| Oct 1, 2020 | Linetsky David71 | SVP, Life Sciences | Sale+OE | 4,477 | $30.97 | $138,667.24 | -1.7% |